Andreas Hugi
Papers
1
Total Citations
14
H-Index
1
About
Andreas Hugi is a pioneering researcher in pulmonary bioengineering, with a focus on developing advanced in vitro models to study human lung responses to environmental exposures. His major contributions center on creating next-generation "lung-on-chip" systems that integrate smoke inhalation technologies, enabling more physiologically relevant simulations of cigarette smoke exposure. His most-cited work, "A next-generation system for smoke inhalation integrated with a breathing lung-on-chip to model human lung responses to cigarette exposure" (2025, 14 citations), addresses critical limitations of animal models by replicating human lung physiology and continuous smoke inhalation. This innovation provides a powerful platform for investigating chronic obstructive pulmonary disease (COPD) and lung cancer mechanisms, offering a more accurate alternative to traditional animal testing. Hugi's research bridges the gap between in vitro and in vivo studies, with his work gaining early recognition for its potential to transform toxicological and pharmacological research. His achievements include developing systems that mimic breathing dynamics, which could accelerate drug discovery and reduce reliance on animal models. As a rising figure in microphysiological systems, Hugi's work promises to reshape how scientists study respiratory diseases and evaluate therapeutic interventions.
Research Focus
Key Achievements
Top Papers
- 1